Bridgefront Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
20,266
+9,286
| +85% | +$726K | 0.42% | 38 |
|
|
2025
Q1 | $796K | Buy |
+10,980
| New | +$796K | 0.23% | 129 |
|
|
2024
Q4 | – | Sell |
-11,458
| Closed | -$756K | – | 640 |
|
|
2024
Q3 | $756K | Buy |
+11,458
| New | +$756K | 0.29% | 90 |
|
|
2023
Q4 | – | Sell |
-16,572
| Closed | -$1.15M | – | 427 |
|
|
2023
Q3 | $1.15M | Buy |
+16,572
| New | +$1.15M | 0.8% | 9 |
|
|
2022
Q4 | – | Sell |
-10,949
| Closed | -$905K | – | 405 |
|
|
2022
Q3 | $905K | Buy |
+10,949
| New | +$905K | 0.93% | 7 |
|
|
2022
Q2 | – | Sell |
-2,815
| Closed | -$331K | – | 334 |
|
|
2022
Q1 | $331K | Buy |
+2,815
| New | +$331K | 0.41% | 83 |
|
|
2021
Q2 | – | Sell |
-5,455
| Closed | -$456K | – | 687 |
|
|
2021
Q1 | $456K | Buy |
5,455
+1,260
| +30% | +$105K | 0.14% | 265 |
|
|
2020
Q4 | $383K | Buy |
+4,195
| New | +$383K | 0.13% | 287 |
|